Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells. - Wikidata - awgldk - TriplyDB

Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.

Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.

http://www.wikidata.org/entity/Q38337142

about

Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies Evolving concepts in cancer therapy through targeting sphingolipid metabolism Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Doxorubicin, DNA torsion, and chromatin dynamics.Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancer Human glycolipid transfer protein gene (GLTP) expression is regulated by Sp1 and Sp3: involvement of the bioactive sphingolipid ceramide Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells.Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis Decreased ceramide transport protein (CERT) function alters sphingomyelin production following UVB irradiation.Ceramide signaling in mammalian epidermis.iNSC suppress macrophage-induced inflammation by repressing COX-2.Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation.Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes.Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling.Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide.Alpha lipoic acid prevents doxorubicin-induced nephrotoxicity by mitigation of oxidative stress, inflammation, and apoptosis in rats.Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis.D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats.Doxorubicin promotes transcriptional upregulation of Cdc25B in cancer cells by releasing Sp1 from the promoter.Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia

P2860

Q24304397-CF804F2E-C52A-4530-839D-D46B335F2FE0 Q24316872-EB29EA29-3470-47DA-BD21-91CD8AA00C5C Q26863646-21DD7C61-7EF6-444A-872D-961E4A2B60C3 Q27335599-08A585DA-225D-4A25-AEC2-B7B6FC781C96 Q33733991-615C3F0C-85B9-4F5E-8EEA-81A2BD1E1950 Q34039414-3836F8B6-5899-4246-B364-DF40960A5741 Q34469733-A0D0F87B-A668-4CB8-96EA-72459F303949 Q34488985-D61E7917-C965-4832-BA72-D263BA0C4AF9 Q36037926-FD774ACC-E49A-438F-97A2-9ACFD4175D7F Q36403166-2F126CD0-DCC6-42AD-8DD8-F8C9BF7AE47C Q36711117-C67AB347-BA96-47FD-A0B5-C45C1D1E1B34 Q37619251-28EA6956-E0CE-4CB7-9F79-BE3B348336EC Q38433794-EA463CB0-C320-4522-96ED-E1287FA0B679 Q38831997-0AF0DEC2-DCF2-4DEA-B95F-5EE5028814E3 Q39421907-B3A6B458-050E-45D3-9598-99684B1C570F Q39880179-837184F4-0898-4DB5-9B9B-A7E16C2DFCEE Q39970739-ECB0C1AB-A331-481E-8568-5899A456B8EE Q41811577-A5263E8D-70A0-4674-B096-BD6873BC5A9A Q46269345-E0D90DA9-692E-4D25-89BD-9E5EF30E3AD0 Q46793487-3B22E9EB-56AB-409D-B64E-D0C24A976D91 Q47220465-5D776A06-DB07-42E1-A9B4-EA9BFE0937F1 Q53241489-FED6AC64-446C-4392-B143-87599D9BC69B Q55056859-A6B5369A-4EA9-434E-9A86-281AD01027EF Q58764409-29CA9646-0FDA-4EFC-8921-5DF902E07D5C

P2860

Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.

http://www.wikidata.org/entity/Q38337142

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Ceramide reduction and transcr ...... rug-resistant HL-60/ADR cells.

@en

type

label

Ceramide reduction and transcr ...... rug-resistant HL-60/ADR cells.

@en

prefLabel

Ceramide reduction and transcr ...... rug-resistant HL-60/ADR cells.

@en

P1433

Q38337142-2FB68B6F-DDC2-4BA8-9999-7447697ED760

P1476

Q38337142-B3EAF4D1-59DD-4473-9C0F-42282FD1B413

P2093

Q38337142-5CC12E9D-6AAC-4136-836D-E1207440A171

Q38337142-6B78E890-5CCB-4DD0-97FC-EC0583C01D6A

Q38337142-84909C61-AA40-48D9-9EDC-002D45F13BEC

Q38337142-B1A01B28-FA84-488A-AB62-D912546FC05F

Q38337142-B92322F8-F06D-4642-9D03-37565D960AFC

Q38337142-E2115AE3-5A4D-4F4F-8A60-2BC917FE3FC1

Q38337142-E994D4FA-250F-4CA2-B732-6703F5C9912C

Q38337142-F1D81A09-10EE-4502-95F7-B63EB3C9F5F6

Q38337142-F393B53A-CF75-47E7-8A21-4C43402FBC28

P304

Q38337142-A6981933-A4A4-484A-BE92-B0E7A988C531

P31

Q38337142-2018C58C-3CCB-458A-A45C-AB43D26DD454

P356

Q38337142-792891A7-F419-42C1-88F1-2DC00E9C0FAD

P407

Q38337142-5C2F1ED6-291E-464D-BCAD-6B94F183D0C6

P433

Q38337142-D58E7D33-4ABF-4CDA-8B46-564F7FB10139

P478

Q38337142-03D651EB-D949-4853-A8E0-FFD5F834F909

P577

Q38337142-F239AED2-D797-4A24-921B-A2D5E120456B

P5875

Q38337142-EFA02AB8-299F-412A-803A-4DA0C30F9E2A

P698

Q38337142-724CB422-B493-463B-8D14-279A22736D24

P356

0008-5472.CAN-03-1476

P1433

Cancer Research

P1476

Ceramide reduction and transcr ...... rug-resistant HL-60/ADR cells.

@en

P2093

Hisanori Umehara

http://www.w3.org/2001/XMLSchema#string

Mitsuru Itoh

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Ichikawa

http://www.w3.org/2001/XMLSchema#string

Syohei Yamaoka

http://www.w3.org/2001/XMLSchema#string

Toshiro Okazaki

http://www.w3.org/2001/XMLSchema#string

Walter M Holleran

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Uchida

http://www.w3.org/2001/XMLSchema#string

Yoshimitsu Taguchi

http://www.w3.org/2001/XMLSchema#string

Yoshio Hirabayashi

http://www.w3.org/2001/XMLSchema#string

P304

6271-6279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-03-1476

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8371002

http://www.w3.org/2001/XMLSchema#string

P698

15342415

http://www.w3.org/2001/XMLSchema#string